---
title: "Citi Reaffirms Their Buy Rating on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288152373.md"
description: "Citi reaffirmed its Buy rating on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252), setting a price target of HK$41.00, while the stock closed at HK$26.60. The broader analyst consensus for the company remains a Strong Buy with an average price target of HK$39.27."
datetime: "2026-05-30T14:35:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288152373.md)
  - [en](https://longbridge.com/en/news/288152373.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288152373.md)
---

# Citi Reaffirms Their Buy Rating on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)

In a report released on May 27, from Citi maintained a Buy rating on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H, with a price target of HK$41.00. The company’s shares closed yesterday at HK$26.60.

### Memorial Day Sale – Claim 70% Off TipRanks

-   Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
-   Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter

Currently, the analyst consensus on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H is a Strong Buy with an average price target of HK$39.27.

### Related Stocks

- [02252.HK](https://longbridge.com/en/quote/02252.HK.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [562600.CN](https://longbridge.com/en/quote/562600.CN.md)
- [159898.CN](https://longbridge.com/en/quote/159898.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [159883.CN](https://longbridge.com/en/quote/159883.CN.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252) Receives a Buy from UBS](https://longbridge.com/en/news/290258988.md)
- [Shanghai MicroPort MedBot (Group) (SEHK:2252) Wins EU CE Mark, Is The Valuation Already Too Rich?](https://longbridge.com/en/news/291619269.md)
- [MicroPort MedBot Forecasts First Semi-Annual Profit on Surging Robot Sales](https://longbridge.com/en/news/293489688.md)
- [MicroPort MedBot Proposes New Share Scheme to Replace Existing Incentive Plans](https://longbridge.com/en/news/286423581.md)
- [MicroPort MedBot Sets 2026 AGM With New Capital Mandates on the Table](https://longbridge.com/en/news/286426445.md)